1. Home
  2. IBKR vs BIIB Comparison

IBKR vs BIIB Comparison

Compare IBKR & BIIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Interactive Brokers Group Inc.

IBKR

Interactive Brokers Group Inc.

N/A

Current Price

$71.64

Market Cap

38.7B

Sector

Finance

ML Signal

N/A

Logo Biogen Inc.

BIIB

Biogen Inc.

N/A

Current Price

$250.64

Market Cap

34.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IBKR
BIIB
Founded
1977
1978
Country
United States
United States
Employees
2998
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.7B
34.5B
IPO Year
2006
1996

Fundamental Metrics

Financial Performance
Metric
IBKR
BIIB
Price
$71.64
$250.64
Analyst Decision
Buy
Buy
Analyst Count
17
36
Target Price
$104.04
★ $268.26
AVG Volume (30 Days)
★ 4.6M
1.1M
Earning Date
10-15-2026
10-28-2026
Dividend Yield
★ 0.79%
N/A
EPS Growth
N/A
★ N/A
EPS
1.98
★ 2.66
Revenue
$2,580,000,000.00
★ $9,890,600,000.00
Revenue This Year
$19.72
$7.00
Revenue Next Year
$19.70
$1.82
P/E Ratio
★ $38.21
$92.96
Revenue Growth
★ 9.04
2.22
52 Week Low
$61.03
$160.36
52 Week High
$98.75
$261.00

Technical Indicators

Market Signals
Indicator
IBKR
BIIB
Relative Strength Index (RSI) 34.73 54.94
Support Level $63.51 $240.00
Resistance Level $91.31 $259.89
Average True Range (ATR) 3.19 7.20
MACD -0.22 -1.24
Stochastic Oscillator 4.92 50.24

Price Performance

Historical Comparison
IBKR
BIIB

About IBKR Interactive Brokers Group Inc.

Interactive Brokers is a large, automated retail and institutional brokerage that boasted nearly $780 billion in customer equity at the end of 2025. The company cut its teeth as a market maker, introducing US financial markets to automated and algorithmic training before expanding into brokerage services in 1993. The firm has a wide-ranging client base, with its best-in-class order execution and extremely low margin lending rates catering to a sophisticated audience of hedge funds, proprietary traders, and introducing brokers that account for about 45% of the firm's commissions. With operations spanning more than 170 electronic exchanges, 40 countries, and 29 currencies, Interactive Brokers caters to a global clientele, with more than 80% of client accounts sitting outside the US.

About BIIB Biogen Inc.

Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).

Share on Social Networks: